why choose us

First received: April 26, 2023

Clinical Trial: Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hematopoietic and Lymphatic System Neoplasm

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer

Brief Summary: This phase I/II trial tests the safety and side effects of psilocybin in combination with therapy for the treatment of patients with metastatic cancer and symptoms of anxiety and/or depression.Psilocybin is a substance being studied in conjunction with therapy for the treatment of anxiety and depression in patients with cancer.In this study, the psilocybin being used is derived from the mushroom psilocybe cubensis using a patented process that results in a pharmaceutical grade version of…

Read more